Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation

By sjmartinez • February 14, 2023

Friend BD, Broglie L, Logan BR, Chhabra S, Bupp C, Schiller G, Beitinjaneh A, Perez MAD, Guilcher GMT, Hashem H, Hildebrandt GC, Krem MM, Lazarus HM, Nishihori T, Nusrat R, Rotz SJ, Wirk B, Wieduwilt M, Pasquini M, Savani BN, Stadtmauer EA, Sorror ML, Thakar MS. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 Feb;29(2):123.e1-123.e10. doi: 10.1016/j.jtct.2022.11.019. Epub 2022 Nov 26. PMID: 36442769; PMCID: PMC9911376.

Tags: Adolescents and young adults (AYA), Allogeneic hematopoietic cell transplantation, comorbidities, HCT-CI, Hematologic malignancies, Hematology/Oncology, Pediatrics, Publications

The association between statin use, genetic variation, and prostate cancer risk

Amiri A, Xu W, Zhang Q, Jeong JH, Freedland SJ, Fleshner NE, Finelli A, Hamilton RJ. The association between statin use, genetic variation, and prostate[...]

Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization Tool

Gresham G, Luu M, Henry NL, Nguyen T, Barnhill K, Yothers G, Kim S, Rogatko A, Attai DJ, Tighiouart M, Hays RD, Ganz PA. Clinician[...]

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Hoff FW, Huang Y, Welkie RL, Swords RT, Traer E, Stein EM, Lin TL, Patel PA, Collins RH Jr, Baer MR, Duong VH, Blum WG,[...]